[Form 4] Allegro MicroSystems, Inc. Insider Trading Activity
Richard R. Lury, a director of Allegro MicroSystems, Inc. (ALGM), reported a non-derivative sale of 7,000 shares of ALGM common stock on 08/12/2025 at a weighted average price of $31.8104 per share (executed across prices from $31.80 to $31.83). After the transaction he directly beneficially owns 18,857 shares.
The Form 4 discloses no derivative transactions and includes an explanatory note about the weighted-average pricing. The filing was submitted by an attorney-in-fact and documents an insider sale but does not include additional company developments or context about the sale's purpose.
- Disclosure transparency: Form 4 reports the sale with a weighted-average price and specifies the execution price range.
- Continued ownership: The reporting director retains 18,857 shares after the sale, showing ongoing direct stake.
- Insider sale recorded: The director sold 7,000 shares, reducing direct holdings to 18,857.
- No additional context provided: The filing does not state the reason for the sale or whether it was part of a pre-arranged plan.
Insights
TL;DR: Director sold 7,000 ALGM shares at ~$31.81, reducing direct holdings to 18,857; only a non-derivative sale is reported.
The filing shows a straightforward Section 16 disclosure: a non-derivative sale of 7,000 shares on 08/12/2025 at a weighted average price of $31.8104, with execution prices ranging $31.80–$31.83. Table II reports no derivative activity. From a market-impact perspective, the form provides clear pricing and post-transaction ownership but contains no information on material corporate events, financing, or insider intent that would change the investment thesis.
TL;DR: Form 4 was filed by an attorney-in-fact, discloses the sale and remaining direct ownership, and reflects compliance with disclosure rules.
The report documents compliance with Section 16 reporting: the director's sale, the weighted-average price, and the director's direct holdings after the sale (18,857 shares). The explanatory note clarifies the weighted-average pricing across a narrow range. No derivatives or other transactions are disclosed. The filing is transparent but does not provide context on the rationale for the sale, which is not required by the Form.